nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2A—vein—testicular cancer	0.00622	0.22	CbGeAlD
Duloxetine—NPY1R—seminal vesicle—testicular cancer	0.00542	0.192	CbGeAlD
Duloxetine—NPY1R—gonad—testicular cancer	0.00392	0.139	CbGeAlD
Duloxetine—NPY1R—testis—testicular cancer	0.00282	0.0999	CbGeAlD
Duloxetine—NPY1R—lymph node—testicular cancer	0.00205	0.0724	CbGeAlD
Duloxetine—SLC6A2—gonad—testicular cancer	0.00133	0.047	CbGeAlD
Duloxetine—SLC6A3—testis—testicular cancer	0.00119	0.042	CbGeAlD
Duloxetine—HTR2A—embryo—testicular cancer	0.00118	0.0416	CbGeAlD
Duloxetine—SLC6A2—testis—testicular cancer	0.000958	0.0339	CbGeAlD
Duloxetine—HTR2A—gonad—testicular cancer	0.000799	0.0283	CbGeAlD
Duloxetine—SLC6A2—lymph node—testicular cancer	0.000695	0.0246	CbGeAlD
Duloxetine—Urinary tract infection—Doxorubicin—testicular cancer	0.0006	0.000617	CcSEcCtD
Duloxetine—Conjunctivitis—Doxorubicin—testicular cancer	0.0006	0.000617	CcSEcCtD
Duloxetine—Haemorrhage—Epirubicin—testicular cancer	0.000599	0.000616	CcSEcCtD
Duloxetine—Hepatitis—Epirubicin—testicular cancer	0.000599	0.000616	CcSEcCtD
Duloxetine—Eye disorder—Methotrexate—testicular cancer	0.000598	0.000615	CcSEcCtD
Duloxetine—Tinnitus—Methotrexate—testicular cancer	0.000597	0.000614	CcSEcCtD
Duloxetine—Hypoaesthesia—Epirubicin—testicular cancer	0.000596	0.000613	CcSEcCtD
Duloxetine—Asthenia—Cisplatin—testicular cancer	0.000594	0.000612	CcSEcCtD
Duloxetine—Pharyngitis—Epirubicin—testicular cancer	0.000594	0.000612	CcSEcCtD
Duloxetine—Cardiac disorder—Methotrexate—testicular cancer	0.000594	0.000611	CcSEcCtD
Duloxetine—CYP2D6—female gonad—testicular cancer	0.000592	0.0209	CbGeAlD
Duloxetine—Urinary tract disorder—Epirubicin—testicular cancer	0.000591	0.000609	CcSEcCtD
Duloxetine—Oedema peripheral—Epirubicin—testicular cancer	0.00059	0.000607	CcSEcCtD
Duloxetine—Connective tissue disorder—Epirubicin—testicular cancer	0.000588	0.000606	CcSEcCtD
Duloxetine—Urethral disorder—Epirubicin—testicular cancer	0.000587	0.000604	CcSEcCtD
Duloxetine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000584	0.000601	CcSEcCtD
Duloxetine—Epistaxis—Doxorubicin—testicular cancer	0.000582	0.000599	CcSEcCtD
Duloxetine—Angiopathy—Methotrexate—testicular cancer	0.000581	0.000597	CcSEcCtD
Duloxetine—Immune system disorder—Methotrexate—testicular cancer	0.000578	0.000595	CcSEcCtD
Duloxetine—Visual impairment—Epirubicin—testicular cancer	0.000577	0.000594	CcSEcCtD
Duloxetine—Mediastinal disorder—Methotrexate—testicular cancer	0.000577	0.000594	CcSEcCtD
Duloxetine—HTR2A—testis—testicular cancer	0.000576	0.0204	CbGeAlD
Duloxetine—Chills—Methotrexate—testicular cancer	0.000574	0.000591	CcSEcCtD
Duloxetine—Nausea—Ifosfamide—testicular cancer	0.000571	0.000587	CcSEcCtD
Duloxetine—Diarrhoea—Cisplatin—testicular cancer	0.000567	0.000583	CcSEcCtD
Duloxetine—Erythema multiforme—Epirubicin—testicular cancer	0.000566	0.000583	CcSEcCtD
Duloxetine—Alopecia—Methotrexate—testicular cancer	0.000565	0.000582	CcSEcCtD
Duloxetine—Mental disorder—Methotrexate—testicular cancer	0.000561	0.000577	CcSEcCtD
Duloxetine—Eye disorder—Epirubicin—testicular cancer	0.00056	0.000576	CcSEcCtD
Duloxetine—Hypersensitivity—Etoposide—testicular cancer	0.000559	0.000575	CcSEcCtD
Duloxetine—Tinnitus—Epirubicin—testicular cancer	0.000558	0.000575	CcSEcCtD
Duloxetine—Erythema—Methotrexate—testicular cancer	0.000557	0.000573	CcSEcCtD
Duloxetine—Malnutrition—Methotrexate—testicular cancer	0.000557	0.000573	CcSEcCtD
Duloxetine—Haemoglobin—Doxorubicin—testicular cancer	0.000557	0.000573	CcSEcCtD
Duloxetine—Flushing—Epirubicin—testicular cancer	0.000556	0.000572	CcSEcCtD
Duloxetine—Cardiac disorder—Epirubicin—testicular cancer	0.000556	0.000572	CcSEcCtD
Duloxetine—Haemorrhage—Doxorubicin—testicular cancer	0.000554	0.00057	CcSEcCtD
Duloxetine—Hepatitis—Doxorubicin—testicular cancer	0.000554	0.00057	CcSEcCtD
Duloxetine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000551	0.000567	CcSEcCtD
Duloxetine—Pharyngitis—Doxorubicin—testicular cancer	0.00055	0.000566	CcSEcCtD
Duloxetine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000547	0.000563	CcSEcCtD
Duloxetine—Oedema peripheral—Doxorubicin—testicular cancer	0.000546	0.000562	CcSEcCtD
Duloxetine—Dysgeusia—Methotrexate—testicular cancer	0.000546	0.000561	CcSEcCtD
Duloxetine—Asthenia—Etoposide—testicular cancer	0.000545	0.00056	CcSEcCtD
Duloxetine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000545	0.00056	CcSEcCtD
Duloxetine—Angiopathy—Epirubicin—testicular cancer	0.000543	0.000559	CcSEcCtD
Duloxetine—Urethral disorder—Doxorubicin—testicular cancer	0.000543	0.000559	CcSEcCtD
Duloxetine—Immune system disorder—Epirubicin—testicular cancer	0.000541	0.000557	CcSEcCtD
Duloxetine—Mediastinal disorder—Epirubicin—testicular cancer	0.00054	0.000555	CcSEcCtD
Duloxetine—Back pain—Methotrexate—testicular cancer	0.000539	0.000555	CcSEcCtD
Duloxetine—Chills—Epirubicin—testicular cancer	0.000537	0.000553	CcSEcCtD
Duloxetine—Pruritus—Etoposide—testicular cancer	0.000537	0.000553	CcSEcCtD
Duloxetine—Arrhythmia—Epirubicin—testicular cancer	0.000535	0.000551	CcSEcCtD
Duloxetine—Visual impairment—Doxorubicin—testicular cancer	0.000534	0.00055	CcSEcCtD
Duloxetine—Alopecia—Epirubicin—testicular cancer	0.000529	0.000545	CcSEcCtD
Duloxetine—Vomiting—Cisplatin—testicular cancer	0.000527	0.000542	CcSEcCtD
Duloxetine—Vision blurred—Methotrexate—testicular cancer	0.000525	0.00054	CcSEcCtD
Duloxetine—Mental disorder—Epirubicin—testicular cancer	0.000525	0.00054	CcSEcCtD
Duloxetine—CYP2D6—testis—testicular cancer	0.000525	0.0186	CbGeAlD
Duloxetine—Erythema multiforme—Doxorubicin—testicular cancer	0.000524	0.000539	CcSEcCtD
Duloxetine—Rash—Cisplatin—testicular cancer	0.000522	0.000538	CcSEcCtD
Duloxetine—Dermatitis—Cisplatin—testicular cancer	0.000522	0.000537	CcSEcCtD
Duloxetine—Malnutrition—Epirubicin—testicular cancer	0.000521	0.000536	CcSEcCtD
Duloxetine—Erythema—Epirubicin—testicular cancer	0.000521	0.000536	CcSEcCtD
Duloxetine—Diarrhoea—Etoposide—testicular cancer	0.000519	0.000534	CcSEcCtD
Duloxetine—Eye disorder—Doxorubicin—testicular cancer	0.000518	0.000533	CcSEcCtD
Duloxetine—Ill-defined disorder—Methotrexate—testicular cancer	0.000517	0.000532	CcSEcCtD
Duloxetine—Tinnitus—Doxorubicin—testicular cancer	0.000517	0.000532	CcSEcCtD
Duloxetine—Anaemia—Methotrexate—testicular cancer	0.000515	0.00053	CcSEcCtD
Duloxetine—Flushing—Doxorubicin—testicular cancer	0.000514	0.000529	CcSEcCtD
Duloxetine—Cardiac disorder—Doxorubicin—testicular cancer	0.000514	0.000529	CcSEcCtD
Duloxetine—Flatulence—Epirubicin—testicular cancer	0.000514	0.000529	CcSEcCtD
Duloxetine—Tension—Epirubicin—testicular cancer	0.000512	0.000526	CcSEcCtD
Duloxetine—Dysgeusia—Epirubicin—testicular cancer	0.000511	0.000525	CcSEcCtD
Duloxetine—Nervousness—Epirubicin—testicular cancer	0.000506	0.000521	CcSEcCtD
Duloxetine—Back pain—Epirubicin—testicular cancer	0.000504	0.000519	CcSEcCtD
Duloxetine—Angiopathy—Doxorubicin—testicular cancer	0.000503	0.000517	CcSEcCtD
Duloxetine—Malaise—Methotrexate—testicular cancer	0.000502	0.000517	CcSEcCtD
Duloxetine—Dizziness—Etoposide—testicular cancer	0.000502	0.000517	CcSEcCtD
Duloxetine—Muscle spasms—Epirubicin—testicular cancer	0.000501	0.000516	CcSEcCtD
Duloxetine—Immune system disorder—Doxorubicin—testicular cancer	0.000501	0.000515	CcSEcCtD
Duloxetine—Vertigo—Methotrexate—testicular cancer	0.0005	0.000515	CcSEcCtD
Duloxetine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000499	0.000514	CcSEcCtD
Duloxetine—Leukopenia—Methotrexate—testicular cancer	0.000499	0.000513	CcSEcCtD
Duloxetine—Chills—Doxorubicin—testicular cancer	0.000497	0.000512	CcSEcCtD
Duloxetine—Arrhythmia—Doxorubicin—testicular cancer	0.000495	0.000509	CcSEcCtD
Duloxetine—Nausea—Cisplatin—testicular cancer	0.000492	0.000506	CcSEcCtD
Duloxetine—Vision blurred—Epirubicin—testicular cancer	0.000491	0.000506	CcSEcCtD
Duloxetine—Alopecia—Doxorubicin—testicular cancer	0.00049	0.000504	CcSEcCtD
Duloxetine—Cough—Methotrexate—testicular cancer	0.000486	0.0005	CcSEcCtD
Duloxetine—Mental disorder—Doxorubicin—testicular cancer	0.000485	0.0005	CcSEcCtD
Duloxetine—Ill-defined disorder—Epirubicin—testicular cancer	0.000484	0.000498	CcSEcCtD
Duloxetine—Convulsion—Methotrexate—testicular cancer	0.000483	0.000497	CcSEcCtD
Duloxetine—Vomiting—Etoposide—testicular cancer	0.000483	0.000497	CcSEcCtD
Duloxetine—Erythema—Doxorubicin—testicular cancer	0.000482	0.000496	CcSEcCtD
Duloxetine—Malnutrition—Doxorubicin—testicular cancer	0.000482	0.000496	CcSEcCtD
Duloxetine—Anaemia—Epirubicin—testicular cancer	0.000482	0.000496	CcSEcCtD
Duloxetine—Agitation—Epirubicin—testicular cancer	0.000479	0.000493	CcSEcCtD
Duloxetine—Rash—Etoposide—testicular cancer	0.000479	0.000492	CcSEcCtD
Duloxetine—Dermatitis—Etoposide—testicular cancer	0.000478	0.000492	CcSEcCtD
Duloxetine—Headache—Etoposide—testicular cancer	0.000475	0.000489	CcSEcCtD
Duloxetine—Flatulence—Doxorubicin—testicular cancer	0.000475	0.000489	CcSEcCtD
Duloxetine—Chest pain—Methotrexate—testicular cancer	0.000474	0.000488	CcSEcCtD
Duloxetine—Arthralgia—Methotrexate—testicular cancer	0.000474	0.000488	CcSEcCtD
Duloxetine—Myalgia—Methotrexate—testicular cancer	0.000474	0.000488	CcSEcCtD
Duloxetine—Tension—Doxorubicin—testicular cancer	0.000473	0.000487	CcSEcCtD
Duloxetine—Dysgeusia—Doxorubicin—testicular cancer	0.000472	0.000486	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000471	0.000485	CcSEcCtD
Duloxetine—Malaise—Epirubicin—testicular cancer	0.00047	0.000484	CcSEcCtD
Duloxetine—Discomfort—Methotrexate—testicular cancer	0.000469	0.000482	CcSEcCtD
Duloxetine—Nervousness—Doxorubicin—testicular cancer	0.000468	0.000482	CcSEcCtD
Duloxetine—Vertigo—Epirubicin—testicular cancer	0.000468	0.000482	CcSEcCtD
Duloxetine—Syncope—Epirubicin—testicular cancer	0.000468	0.000481	CcSEcCtD
Duloxetine—Leukopenia—Epirubicin—testicular cancer	0.000467	0.00048	CcSEcCtD
Duloxetine—Back pain—Doxorubicin—testicular cancer	0.000467	0.00048	CcSEcCtD
Duloxetine—Muscle spasms—Doxorubicin—testicular cancer	0.000464	0.000477	CcSEcCtD
Duloxetine—Palpitations—Epirubicin—testicular cancer	0.000461	0.000474	CcSEcCtD
Duloxetine—Confusional state—Methotrexate—testicular cancer	0.000458	0.000472	CcSEcCtD
Duloxetine—Loss of consciousness—Epirubicin—testicular cancer	0.000458	0.000472	CcSEcCtD
Duloxetine—Cough—Epirubicin—testicular cancer	0.000455	0.000468	CcSEcCtD
Duloxetine—Anaphylactic shock—Methotrexate—testicular cancer	0.000455	0.000468	CcSEcCtD
Duloxetine—Vision blurred—Doxorubicin—testicular cancer	0.000455	0.000468	CcSEcCtD
Duloxetine—Convulsion—Epirubicin—testicular cancer	0.000452	0.000465	CcSEcCtD
Duloxetine—Infection—Methotrexate—testicular cancer	0.000452	0.000465	CcSEcCtD
Duloxetine—Nausea—Etoposide—testicular cancer	0.000451	0.000464	CcSEcCtD
Duloxetine—Hypertension—Epirubicin—testicular cancer	0.00045	0.000463	CcSEcCtD
Duloxetine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000448	0.000461	CcSEcCtD
Duloxetine—Nervous system disorder—Methotrexate—testicular cancer	0.000446	0.000459	CcSEcCtD
Duloxetine—Anaemia—Doxorubicin—testicular cancer	0.000446	0.000459	CcSEcCtD
Duloxetine—Thrombocytopenia—Methotrexate—testicular cancer	0.000445	0.000458	CcSEcCtD
Duloxetine—Chest pain—Epirubicin—testicular cancer	0.000444	0.000457	CcSEcCtD
Duloxetine—Myalgia—Epirubicin—testicular cancer	0.000444	0.000457	CcSEcCtD
Duloxetine—Arthralgia—Epirubicin—testicular cancer	0.000444	0.000457	CcSEcCtD
Duloxetine—Agitation—Doxorubicin—testicular cancer	0.000443	0.000456	CcSEcCtD
Duloxetine—Anxiety—Epirubicin—testicular cancer	0.000442	0.000455	CcSEcCtD
Duloxetine—Skin disorder—Methotrexate—testicular cancer	0.000442	0.000454	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000441	0.000454	CcSEcCtD
Duloxetine—Hyperhidrosis—Methotrexate—testicular cancer	0.00044	0.000452	CcSEcCtD
Duloxetine—Discomfort—Epirubicin—testicular cancer	0.000439	0.000451	CcSEcCtD
Duloxetine—Malaise—Doxorubicin—testicular cancer	0.000435	0.000448	CcSEcCtD
Duloxetine—Dry mouth—Epirubicin—testicular cancer	0.000434	0.000447	CcSEcCtD
Duloxetine—Vertigo—Doxorubicin—testicular cancer	0.000433	0.000446	CcSEcCtD
Duloxetine—Anorexia—Methotrexate—testicular cancer	0.000433	0.000446	CcSEcCtD
Duloxetine—Syncope—Doxorubicin—testicular cancer	0.000433	0.000445	CcSEcCtD
Duloxetine—Leukopenia—Doxorubicin—testicular cancer	0.000432	0.000444	CcSEcCtD
Duloxetine—Confusional state—Epirubicin—testicular cancer	0.000429	0.000441	CcSEcCtD
Duloxetine—Palpitations—Doxorubicin—testicular cancer	0.000426	0.000439	CcSEcCtD
Duloxetine—Oedema—Epirubicin—testicular cancer	0.000425	0.000438	CcSEcCtD
Duloxetine—Anaphylactic shock—Epirubicin—testicular cancer	0.000425	0.000438	CcSEcCtD
Duloxetine—Loss of consciousness—Doxorubicin—testicular cancer	0.000424	0.000436	CcSEcCtD
Duloxetine—Infection—Epirubicin—testicular cancer	0.000423	0.000435	CcSEcCtD
Duloxetine—Cough—Doxorubicin—testicular cancer	0.000421	0.000433	CcSEcCtD
Duloxetine—Shock—Epirubicin—testicular cancer	0.000419	0.000431	CcSEcCtD
Duloxetine—Convulsion—Doxorubicin—testicular cancer	0.000418	0.00043	CcSEcCtD
Duloxetine—Nervous system disorder—Epirubicin—testicular cancer	0.000417	0.000429	CcSEcCtD
Duloxetine—Thrombocytopenia—Epirubicin—testicular cancer	0.000417	0.000429	CcSEcCtD
Duloxetine—Hypertension—Doxorubicin—testicular cancer	0.000416	0.000429	CcSEcCtD
Duloxetine—Tachycardia—Epirubicin—testicular cancer	0.000415	0.000427	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000414	0.000426	CcSEcCtD
Duloxetine—Skin disorder—Epirubicin—testicular cancer	0.000413	0.000425	CcSEcCtD
Duloxetine—Hyperhidrosis—Epirubicin—testicular cancer	0.000411	0.000423	CcSEcCtD
Duloxetine—Insomnia—Methotrexate—testicular cancer	0.000411	0.000423	CcSEcCtD
Duloxetine—Chest pain—Doxorubicin—testicular cancer	0.000411	0.000423	CcSEcCtD
Duloxetine—Myalgia—Doxorubicin—testicular cancer	0.000411	0.000423	CcSEcCtD
Duloxetine—Arthralgia—Doxorubicin—testicular cancer	0.000411	0.000423	CcSEcCtD
Duloxetine—Anxiety—Doxorubicin—testicular cancer	0.000409	0.000421	CcSEcCtD
Duloxetine—Paraesthesia—Methotrexate—testicular cancer	0.000408	0.00042	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000408	0.00042	CcSEcCtD
Duloxetine—Discomfort—Doxorubicin—testicular cancer	0.000406	0.000418	CcSEcCtD
Duloxetine—Anorexia—Epirubicin—testicular cancer	0.000406	0.000417	CcSEcCtD
Duloxetine—Somnolence—Methotrexate—testicular cancer	0.000404	0.000416	CcSEcCtD
Duloxetine—Dry mouth—Doxorubicin—testicular cancer	0.000402	0.000413	CcSEcCtD
Duloxetine—Dyspepsia—Methotrexate—testicular cancer	0.0004	0.000412	CcSEcCtD
Duloxetine—Confusional state—Doxorubicin—testicular cancer	0.000397	0.000408	CcSEcCtD
Duloxetine—Decreased appetite—Methotrexate—testicular cancer	0.000395	0.000407	CcSEcCtD
Duloxetine—Oedema—Doxorubicin—testicular cancer	0.000394	0.000405	CcSEcCtD
Duloxetine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000394	0.000405	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000393	0.000404	CcSEcCtD
Duloxetine—Fatigue—Methotrexate—testicular cancer	0.000392	0.000403	CcSEcCtD
Duloxetine—Infection—Doxorubicin—testicular cancer	0.000391	0.000402	CcSEcCtD
Duloxetine—Pain—Methotrexate—testicular cancer	0.000389	0.0004	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000388	0.000399	CcSEcCtD
Duloxetine—Shock—Doxorubicin—testicular cancer	0.000387	0.000399	CcSEcCtD
Duloxetine—Nervous system disorder—Doxorubicin—testicular cancer	0.000386	0.000397	CcSEcCtD
Duloxetine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000385	0.000397	CcSEcCtD
Duloxetine—Insomnia—Epirubicin—testicular cancer	0.000385	0.000396	CcSEcCtD
Duloxetine—Tachycardia—Doxorubicin—testicular cancer	0.000384	0.000395	CcSEcCtD
Duloxetine—Skin disorder—Doxorubicin—testicular cancer	0.000382	0.000394	CcSEcCtD
Duloxetine—Paraesthesia—Epirubicin—testicular cancer	0.000382	0.000393	CcSEcCtD
Duloxetine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000381	0.000392	CcSEcCtD
Duloxetine—Somnolence—Epirubicin—testicular cancer	0.000378	0.000389	CcSEcCtD
Duloxetine—Anorexia—Doxorubicin—testicular cancer	0.000375	0.000386	CcSEcCtD
Duloxetine—Feeling abnormal—Methotrexate—testicular cancer	0.000375	0.000386	CcSEcCtD
Duloxetine—Dyspepsia—Epirubicin—testicular cancer	0.000375	0.000385	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000372	0.000383	CcSEcCtD
Duloxetine—Decreased appetite—Epirubicin—testicular cancer	0.00037	0.000381	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000367	0.000378	CcSEcCtD
Duloxetine—Fatigue—Epirubicin—testicular cancer	0.000367	0.000377	CcSEcCtD
Duloxetine—Constipation—Epirubicin—testicular cancer	0.000364	0.000374	CcSEcCtD
Duloxetine—Pain—Epirubicin—testicular cancer	0.000364	0.000374	CcSEcCtD
Duloxetine—Urticaria—Methotrexate—testicular cancer	0.000361	0.000372	CcSEcCtD
Duloxetine—Abdominal pain—Methotrexate—testicular cancer	0.000359	0.00037	CcSEcCtD
Duloxetine—Body temperature increased—Methotrexate—testicular cancer	0.000359	0.00037	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000359	0.000369	CcSEcCtD
Duloxetine—Insomnia—Doxorubicin—testicular cancer	0.000356	0.000366	CcSEcCtD
Duloxetine—Paraesthesia—Doxorubicin—testicular cancer	0.000353	0.000364	CcSEcCtD
Duloxetine—Feeling abnormal—Epirubicin—testicular cancer	0.000351	0.000361	CcSEcCtD
Duloxetine—Somnolence—Doxorubicin—testicular cancer	0.00035	0.00036	CcSEcCtD
Duloxetine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000348	0.000358	CcSEcCtD
Duloxetine—Dyspepsia—Doxorubicin—testicular cancer	0.000347	0.000357	CcSEcCtD
Duloxetine—Decreased appetite—Doxorubicin—testicular cancer	0.000342	0.000352	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00034	0.00035	CcSEcCtD
Duloxetine—Fatigue—Doxorubicin—testicular cancer	0.000339	0.000349	CcSEcCtD
Duloxetine—Urticaria—Epirubicin—testicular cancer	0.000338	0.000348	CcSEcCtD
Duloxetine—Pain—Doxorubicin—testicular cancer	0.000337	0.000346	CcSEcCtD
Duloxetine—Constipation—Doxorubicin—testicular cancer	0.000337	0.000346	CcSEcCtD
Duloxetine—Body temperature increased—Epirubicin—testicular cancer	0.000336	0.000346	CcSEcCtD
Duloxetine—Abdominal pain—Epirubicin—testicular cancer	0.000336	0.000346	CcSEcCtD
Duloxetine—Hypersensitivity—Methotrexate—testicular cancer	0.000335	0.000345	CcSEcCtD
Duloxetine—Asthenia—Methotrexate—testicular cancer	0.000326	0.000336	CcSEcCtD
Duloxetine—Feeling abnormal—Doxorubicin—testicular cancer	0.000324	0.000334	CcSEcCtD
Duloxetine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000322	0.000331	CcSEcCtD
Duloxetine—Pruritus—Methotrexate—testicular cancer	0.000322	0.000331	CcSEcCtD
Duloxetine—Hypersensitivity—Epirubicin—testicular cancer	0.000313	0.000323	CcSEcCtD
Duloxetine—Urticaria—Doxorubicin—testicular cancer	0.000313	0.000322	CcSEcCtD
Duloxetine—Body temperature increased—Doxorubicin—testicular cancer	0.000311	0.00032	CcSEcCtD
Duloxetine—Abdominal pain—Doxorubicin—testicular cancer	0.000311	0.00032	CcSEcCtD
Duloxetine—Diarrhoea—Methotrexate—testicular cancer	0.000311	0.00032	CcSEcCtD
Duloxetine—Asthenia—Epirubicin—testicular cancer	0.000305	0.000314	CcSEcCtD
Duloxetine—Pruritus—Epirubicin—testicular cancer	0.000301	0.00031	CcSEcCtD
Duloxetine—Dizziness—Methotrexate—testicular cancer	0.000301	0.000309	CcSEcCtD
Duloxetine—Diarrhoea—Epirubicin—testicular cancer	0.000291	0.0003	CcSEcCtD
Duloxetine—Hypersensitivity—Doxorubicin—testicular cancer	0.00029	0.000298	CcSEcCtD
Duloxetine—Vomiting—Methotrexate—testicular cancer	0.000289	0.000297	CcSEcCtD
Duloxetine—Rash—Methotrexate—testicular cancer	0.000287	0.000295	CcSEcCtD
Duloxetine—Dermatitis—Methotrexate—testicular cancer	0.000286	0.000295	CcSEcCtD
Duloxetine—Headache—Methotrexate—testicular cancer	0.000285	0.000293	CcSEcCtD
Duloxetine—Asthenia—Doxorubicin—testicular cancer	0.000282	0.000291	CcSEcCtD
Duloxetine—Dizziness—Epirubicin—testicular cancer	0.000281	0.00029	CcSEcCtD
Duloxetine—Pruritus—Doxorubicin—testicular cancer	0.000279	0.000287	CcSEcCtD
Duloxetine—Vomiting—Epirubicin—testicular cancer	0.000271	0.000278	CcSEcCtD
Duloxetine—Nausea—Methotrexate—testicular cancer	0.00027	0.000278	CcSEcCtD
Duloxetine—Diarrhoea—Doxorubicin—testicular cancer	0.000269	0.000277	CcSEcCtD
Duloxetine—Rash—Epirubicin—testicular cancer	0.000268	0.000276	CcSEcCtD
Duloxetine—Dermatitis—Epirubicin—testicular cancer	0.000268	0.000276	CcSEcCtD
Duloxetine—Headache—Epirubicin—testicular cancer	0.000267	0.000274	CcSEcCtD
Duloxetine—Dizziness—Doxorubicin—testicular cancer	0.00026	0.000268	CcSEcCtD
Duloxetine—Nausea—Epirubicin—testicular cancer	0.000253	0.00026	CcSEcCtD
Duloxetine—Vomiting—Doxorubicin—testicular cancer	0.00025	0.000258	CcSEcCtD
Duloxetine—Rash—Doxorubicin—testicular cancer	0.000248	0.000255	CcSEcCtD
Duloxetine—Dermatitis—Doxorubicin—testicular cancer	0.000248	0.000255	CcSEcCtD
Duloxetine—Headache—Doxorubicin—testicular cancer	0.000247	0.000254	CcSEcCtD
Duloxetine—Nausea—Doxorubicin—testicular cancer	0.000234	0.000241	CcSEcCtD
